doi: 10.1186/s12940-025-01208-0
In type 2 diabetes populations across 38 phase III/IV trials, the rate was lower at 19.3% versus 6.5% on placebo
Semaglutide GLP-1 works by increasing feelings of fullness and slowing down gastric emptying, which can lead to a significant reduction in food intake
Pfizer: Acquisition spree comparison Two blockbuster-funded deal waves, different playbooks Filed Under: Metabolic disease/endicrinology Brian Buntz As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology
June 11, 2024: The JPML selected a new judge to oversee the GLP-1 products liability MDL, which includes lawsuits against Mounjaro and other similar weight loss drugs
If a clinician recommends them, youll need to take them along with diet changes and increased exercise to help you manage your body weight and belly fat